StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)

Close on Nov 17, 2026Market cap $140.36MP/E –Yield –

Drugs Made In America Acquisition II cash

Cash and short-term investments held at the end of each period.

Drugs Made In America Acquisition II's cash was $118.23K at Sep 30, 2026. For fiscal 2025 it was $223, down 98.7% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$223-98.7%
FY2024Dec 31, 2024$17.04K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$118.23K-62.5%
Q2 FY2026Jun 30, 2026$174.97K+3882.1%
Q1 FY2026Mar 31, 2026$347.72K+4873.8%
Q4 FY2025Dec 31, 2025$223-98.7%
Q3 FY2025Sep 30, 2025$315.09K+162.4%
Q2 FY2025Jun 30, 2025$4.39K–
Q1 FY2025Mar 31, 2025$6.99K–
Q4 FY2024Dec 31, 2024$17.04K–
Q3 FY2024Sep 30, 2024$120.07K–

More Drugs Made In America Acquisition II figures

See a number that looks wrong?